In a funding climate where many startups now need revenue, a roadmap, and perhaps a minor miracle to get a Series A, Mira Murati’s Thinking Machines Lab just secured roughly $2 billion at a $12 billion valuation before launching a single product.…
Biopharma spent 2025 behaving like a sector that has finally read the fine print on the cost of capital—and decided to let someone else pick up the bar tab. Licensing and M&A stepped into the role IPOs used to play, and did…